Literature DB >> 30556093

Prevalence of growth and endocrine disorders in Malaysian children with transfusion-dependent thalassaemia.

Khian Aun Tan1, Su Han Lum1, Abqariyah Yahya2, Shekhar Krishnan1, Muhammad Yazid Jalaludin1, Way Seah Lee1.   

Abstract

INTRODUCTION: Endocrine dysfunction due to iron overload secondary to frequent blood transfusions is a common complication in children with transfusion-dependent thalassaemia (TDT). We ascertained the prevalence of endocrine dysfunction in children with TDT seen in a hospital setting in Malaysia.
METHODS: We reviewed all patients with TDT who had ≥ 8 blood transfusions per year. Patients who had a history of stem cell transplantation, concurrent autoimmune diseases or were newly diagnosed to have TDT were excluded. Standard diagnostic criteria were used in the diagnosis of various endocrine dysfunctions.
RESULTS: Of the 82 patients with TDT, 65% had at least one endocrine dysfunction. Short stature was the commonest (40.2%), followed by pubertal disorders (14.6%), hypoparathyroidism (12.3%), vitamin D deficiency (10.1%), hypocortisolism (7.3%), diabetes mellitus (5.2%) and overt hypothyroidism (4.9%). Subclinical hypothyroidism and pre-diabetes mellitus were seen in 13.4% and 8.6% of the patients, respectively. For children aged < 10 years, the prevalence of both thyroid dysfunction and hypoparathyroidism was 9.1%.
CONCLUSION: Two-thirds of children with TDT experienced at least one endocrine dysfunction. Thyroid dysfunction and hypoparathyroidism may be missed if endocrine screening is only performed in children with TDT > 10 years of age. Close monitoring for endocrine dysfunction and hormonal therapy is essential to prevent long-term adverse outcomes. Copyright: © Singapore Medical Association.

Entities:  

Keywords:  endocrine disorders; iron overload; transfusion-dependent thalassaemia

Mesh:

Year:  2018        PMID: 30556093      PMCID: PMC6595058          DOI: 10.11622/smedj.2018155

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  15 in total

1.  Endocrinopathies in Turkish children with Beta thalassemia major: results from a single center study.

Authors:  Pamir Isik; Nese Yarali; Betül Tavil; Fatma Demirel; Gülşah Bayram Karacam; Rukiye Unsal Sac; Ali Fettah; Serdar Ozkasap; Abdurrahman Kara; Bahattin Tunc
Journal:  Pediatr Hematol Oncol       Date:  2014-05-22       Impact factor: 1.969

2.  ISPAD clinical practice consensus guidelines 2009 compendium. Introduction.

Authors:  Ragnar Hanas; Kim C Donaghue; Georgeanna Klingensmith; Peter G F Swift
Journal:  Pediatr Diabetes       Date:  2009-09       Impact factor: 4.866

3.  WHO Child Growth Standards based on length/height, weight and age.

Authors: 
Journal:  Acta Paediatr Suppl       Date:  2006-04

4.  Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America.

Authors:  Maria G Vogiatzi; Eric A Macklin; Felicia L Trachtenberg; Ellen B Fung; Angela M Cheung; Elliott Vichinsky; Nancy Olivieri; Melody Kirby; Janet L Kwiatkowski; Melody Cunningham; Ingrid A Holm; Martin Fleisher; Robert W Grady; Charles M Peterson; Patricia J Giardina
Journal:  Br J Haematol       Date:  2009-07-13       Impact factor: 6.998

5.  Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.

Authors:  Caterina Borgna-Pignatti; Simone Rugolotto; Piero De Stefano; Huaqing Zhao; Maria Domenica Cappellini; Giovanni Carlo Del Vecchio; Maria Antonietta Romeo; Gian Luca Forni; Maria Rita Gamberini; Roberta Ghilardi; Antonio Piga; Avital Cnaan
Journal:  Haematologica       Date:  2004-10       Impact factor: 9.941

6.  Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF).

Authors:  Vincenzo De Sanctis; Androulla Eleftheriou; Cristina Malaventura
Journal:  Pediatr Endocrinol Rev       Date:  2004-12

7.  Marked biological variance in endocrine and biochemical markers in childhood: establishment of pediatric reference intervals using healthy community children from the CALIPER cohort.

Authors:  Dana Bailey; David Colantonio; Lianna Kyriakopoulou; Ashley H Cohen; Man Khun Chan; David Armbruster; Khosrow Adeli
Journal:  Clin Chem       Date:  2013-05-01       Impact factor: 8.327

8.  Cortisol response to low dose versus standard dose (back-to-back) adrenocorticotrophic stimulation tests in children and young adults with thalassemia major.

Authors:  Ashraf T Soliman; Mohamed Yassin; Nadra M S Abdel Majuid; Aml Sabt; Mohamed O Abdulrahman; Vincenzo De Sanctis
Journal:  Indian J Endocrinol Metab       Date:  2013-11

9.  Endocrine profile of β-thalassemia major patients followed from childhood to advanced adulthood in a tertiary care center.

Authors:  Vincenzo De Sanctis; Heba Elsedfy; Ashraf T Soliman; Ihab Zaki Elhakim; Nada A Soliman; Rania Elalaily; Christos Kattamis
Journal:  Indian J Endocrinol Metab       Date:  2016 Jul-Aug

10.  A cross-sectional study of metabolic and endocrine complications in beta-thalassemia major.

Authors:  Farzad Najafipour; Akbar Aliasgarzadeh; Naser Aghamohamadzadeh; Amir Bahrami; Majid Mobasri; Mitra Niafar; Manouchehr Khoshbaten
Journal:  Ann Saudi Med       Date:  2008 Sep-Oct       Impact factor: 1.526

View more
  1 in total

1.  Observational study on the current status of thalassaemia in Malaysia: a report from the Malaysian Thalassaemia Registry.

Authors:  Hishamshah Mohd Ibrahim; Zulaiha Muda; Ida Shahnaz Othman; Mohamed Najib Mohamed Unni; Kok Hoi Teh; Asohan Thevarajah; Kogilavani Gunasagaran; Gek Bee Ong; Seoh Leng Yeoh; Aisyah Muhammad Rivai; Che Hadibiah Che Mohd Razali; Nazzlin Dizana Din; Zarina Abdul Latiff; Rahman Jamal; Norsarwany Mohamad; Hany Mohd Ariffin; Hamidah Alias
Journal:  BMJ Open       Date:  2020-06-29       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.